Form 8.3 - Allergan plc

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Allergan plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BY9D5467

Date of dealing

21st April 2020

2. INTERESTS AND SHORT POSITIONS

a) Interests and short positions (following dealing) in the class ofrelevant security dealt in(Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

4,272,319

(1.298%)

4,997

(0.002%)

(2) Derivatives (other than options)

-

-

(3) Options and agreements to purchase/sell

-

-

Total

4,272,319

(1.298%)

4,997

(0.002%)

 

b) Interests and short positionsin relevant securitiesof the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit (Note 5)

(USD)

Purchase

50,980

184.04

Sale

4,766

184.04

Purchase

25,775

184.04

Sale

300

184.15

Sale

200

184.24

Sale

200

184.56

Sale

100

184.42

Sale

100

184.26

Sale

200

184.29

Sale

100

184.08

Sale

200

184.14

Sale

100

184.16

Sale

100

184.30

Sale

200

184.27

Sale

105

184.50

Sale

95

184.51

Sale

100

184.62

Sale

100

184.37

Sale

256

184.22

Sale

100

184.23

Sale

200

184.44

Sale

100

184.55

Sale

200

184.43

Sale

100

184.63

Sale

100

184.75

Sale

100

184.18

Sale

100

184.33

Sale

100

184.53

Sale

81

184.68

Sale

200

184.54

Sale

100

184.17

Sale

100

184.21

Sale

100

184.47

Sale

100

184.36

Sale

100

184.67

Sale

100

184.70

Sale

100

184.01

Sale

100

184.38

Sale

1,188

185.85

Purchase

1,584

184.04

Purchase

200

185.82

Purchase

350

185.61

Purchase

110

185.45

Purchase

100

185.62

Purchase

90

185.39

Purchase

349

185.93

Purchase

900

184.75

Purchase

1,887

184.19

Purchase

102

184.68

Purchase

4,900

185.18

Purchase

9,086

184.04

Purchase

100

184.73

Purchase

100

184.49

Purchase

98

184.70

Sale

544

185.84

Sale

200

185.87

Purchase

196

185.85

Sale

300

185.85

Sale

100

185.81

Sale

200

185.93

Sale

196

184.04

Purchase

100

185.78

Purchase

100

184.95

Purchase

2

185.96

Purchase

100

185.80

Purchase

100

185.81

Purchase

75

184.24

Sale

101

184.56

Sale

2

184.42

Purchase

271

184.26

Sale

28

184.26

Sale

3

184.29

Sale

2

184.35

Purchase

200

184.98

Purchase

300

185.77

Purchase

75

185.74

Purchase

200

184.16

Sale

2

184.16

Sale

1

184.27

Sale

36

184.50

Sale

21

184.51

Sale

3

184.62

Purchase

70

184.37

Purchase

132

184.88

Sale

119

184.44

Sale

102

184.55

Sale

3

184.63

Purchase

300

184.74

Sale

10

184.75

Purchase

300

184.18

Purchase

100

184.19

Sale

1,887

184.19

Sale

3

184.33

Sale

1

184.68

Purchase

100

184.82

Sale

2

184.21

Sale

2,253

184.52

Purchase

44,552

184.04

Sale

76,755

184.04

Sale

322

184.36

Sale

1,942

184.58

Sale

114

184.59

Sale

2

184.32

Sale

99

184.46

Sale

3

184.65

Sale

9

184.69

Sale

600

184.39

Sale

100

184.73

Purchase

32

184.84

Sale

10

184.84

Sale

200

184.45

Sale

100

184.80

Sale

1

184.20

Sale

40

184.66

Sale

7

184.72

Sale

2

184.93

Sale

5

184.81

Sale

109

184.40

Sale

36,277

184.04

i) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

b) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

 


 

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

22nd April 2020

Contact name

Milos Naumovic

Telephone number

+44 203 650 8203

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

Short Name: MILLENNIUM PARTNERS, L.P.
Category Code: RET
Sequence Number: 697805
Time of Receipt (offset from UTC): 20200422T124008+0100

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.